Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Study Examining the Efficacy and Cardiovascular Risk of Immediate Versus Deferred Switch From a Boosted PI to Dolutegravir (DTG) in HIV Infected Patients With Stable Virological Suppression

NCT02098837 is registered in ClinicalTrials.gov with St Stephens Aids Trust as lead sponsor.

NCT NCT02098837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02098837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Study Examining the Efficacy and Cardiovascular Risk of Immediate Versus Deferred Switch From a Boosted PI to Dolutegravir (DTG) in HIV Infected Patients With Stable Virological Suppression
Lead sponsor
St Stephens Aids Trust
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
December 4, 2017
Enrollment
415 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

hiv